4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-16-150568
Chief Scientific Officer sold 32,500 shares at $65.00 ($2,112,500)
- Chief Scientific Officer acquired 27,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Biller Scott · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-14 | Sale : show line 1 in the form | −5,000 | $65.00 | $325,000 | 6,000 | I |
| 2016-11-14 | Exercise or conversion : show line 2 in the form | +6,889 | $0.47 | $3,221 | 55,159 | D |
| 2016-11-14 | Exercise or conversion : show line 3 in the form | +14,091 | $9.05 | $127,524 | 69,250 | D |
| 2016-11-14 | Exercise or conversion : show line 4 in the form | +6,520 | $31.64 | $206,293 | 75,770 | D |
| 2016-11-14 | Sale : show line 5 in the form | −27,500 | $65.00 | $1,787,500 | 48,270 | D |
| Open-market sales · 32,500 sh · avg $65.00 · $2,112,500 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-11-14 | Exercise or conversion : show line 6 in the form Stock option (right to buy) | −6,889 | 5,474 | D |
| 2016-11-14 | Exercise or conversion : show line 7 in the form Stock option (right to buy) | −14,091 | 20,000 | D |
| 2016-11-14 | Exercise or conversion : show line 8 in the form Stock option (right to buy) | −6,520 | 35,286 | D |
Loading xslF345X03/doc4.xml…